We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1,651.00 | 1,651.00 | 1,652.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.79 | 67.97B |
From Apr 2019 to Apr 2024
By Tapan Panchal
LONDON--GlaxoSmithKline PLC (GSK.LN) confirmed on Thursday that Philip Hampton, the current chairman of Royal Bank of Scotland Group PLC (RBS.LN), will become the chairman of the pharmaceutical company on May 7.
Mr. Hampton was named as the new chairman in September. He will replace Christopher Gent, who will step down at the annual general meeting on May 7. Mr. Hampton will first become deputy chairman on April 1 and then take over as chairman at the end of the annual meeting.
Mr. Hampton will remain chairman of Royal Bank of Scotland until Aug. 31, Glaxo said.
Write to Tapan Panchal at tapan.panchal@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
